Torrent Pharmaceuticals Limited has informed the Exchange regarding allotment of 1099000 securities pursuant to Non Convertible Securities at its meeting held on January 19, 2026
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals has allotted 1,099,000 non-convertible securities (NCDs) following a board meeting held on January 19, 2026. Non-convertible securities are debt instruments that cannot be converted into equity shares. The company has informed the stock exchange about this allotment as per regulatory disclosure requirements. The announcement does not specify the coupon rate, total issue size in monetary terms, or the purpose of raising these funds. NCDs are typically issued by companies to raise long-term debt capital from investors.
Shareholders should note this is a debt raise, not an equity dilution event, so there is no direct dilution of equity holdings. The financial terms and end-use of funds will determine whether this impacts the company's debt levels and future interest obligations.